Jim Simons Greenwich Life Sciences, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 37,500 shares of GLSI stock, worth $647,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,500
Previous 36,600
2.46%
Holding current value
$647,250
Previous $385,000
94.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding GLSI
# of Institutions
31Shares Held
645KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA223KShares$3.85 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny63.8KShares$1.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA58.2KShares$1.01 Million0.0% of portfolio
-
Black Rock Inc. New York, NY56.5KShares$974,4820.0% of portfolio
-
Goldman Sachs Group Inc New York, NY41.5KShares$716,3760.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $222M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...